Where does The Translational Genomics Research Institute rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), The Translational Genomics Research Institute ranks #3,513 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does The Translational Genomics Research Institute hold?

The Translational Genomics Research Institute holds 105 US utility patents granted between 2015 and 2025, spanning 23 technology areas.

What is The Translational Genomics Research Institute's Innovation Score?

The Translational Genomics Research Institute has an Innovation Score of 45.0 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is The Translational Genomics Research Institute's patent grant rate increasing or decreasing?

The Translational Genomics Research Institute's recent grant velocity is -38% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for The Translational Genomics Research Institute's patents?

The Translational Genomics Research Institute's patents average 14.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView US Corporation

The Translational Genomics Research Institute

Q: What technology areas does The Translational Genomics Research Institute focus on?

The Translational Genomics Research Institute's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 66 patents, ranking #67 of 2,502 assignees active in that subclass. Grants appear in 23 CPC subclasses total.

Q: How is the The Translational Genomics Research Institute patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 105 granted patents across 23 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, The ranks #3,513 of 49,997 tracked US assignees by granted-patent volume, with 105 patents across 23 technology areas.

#3,513
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.0/100): 14.1
avg claims per patent: -38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3513 · US Corporation #3,513 · 105 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 105 grants
TOP-DECILE #3,513/49,997
PHOTO-FINISH Sony Pictures…
CPC-FOCUS C12Q · 23 areas
INNOV-PAR 45.0/100
CLAIMS-RICH 14.1 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sony Pictures Entertainment Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How The’s 45.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.1 pts (36%) Velocity 3.4 pts (8%) Breadth 17.0 pts (38%) Claim depth 8.5 pts (19%)

Qualcomm Incorporated · highest

85
Changchun Institute… · near

45
Harman Professional… · near

45
The Translational… · this assignee

45
Arbor Networks · near

45
Icom Incorporated · near

45
3D Lighting… · lowest

7

What this shows The's Innovation Score is 45.0/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for The?

Each dot is one of The’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). The’s own 14.1 claims/patent is at or below the 18.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

The vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where The's grants concentrate

The Translational Genomics Research Institute is a focused PatentsView assignee: 23 CPC subclasses with 62.9% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2015 (14 grants) versus a trough of 4 in 2023. By volume, The sits between Sony Pictures Entertainment Inc. and Valencell, Inc..

The's three-year grant acceleration

From 2019–2021 to 2022–2024, The Translational Genomics Research Institute moved from 33 to 17 grants (0.52x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,653. See the growth leaderboard.

Sony Pictures Ent…

105
Spirent Communica…

105
Teledyne Scientif…

105
Tianma Japan

105
Thomson Reuters G…

105
University of Mar…

105
Varex Imaging

105
Valencell

105
The Translational… ◀

105

What this shows The holds 105 patents at rank #3,514, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near The

By rank, the assignees closest to #3,514 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in The's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for The, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), The ranks #67 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Changchun Institute of Applied Chemistry Chinese Academy of Sciences 45 Harman Professional Denmark Aps 45 Arbor Networks, Inc. 45 Icom Incorporated 45

Similar claim depth

Nearest assignees by average claims per patent (14.1 here).

Nextracker LLC 14.1 avg University of Puerto Rico 14.1 avg Knorr-bremse Systeme fuer Nutzfahrzeuge GmbH 14.1 avg MAN Truck & Bus SE 14.1 avg

The's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

The Translational Genomics Research Institute patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	14	13.3%
2016	14	13.3%
2017	11	10.5%
2018	10	9.5%
2019	12	11.4%
2020	13	12.4%
2021	8	7.6%
2022	6	5.7%
2023	4	3.8%
2024	7	6.7%
2025partial year	6	5.7%

Which technologies does The Translational Genomics Research Institute patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 66

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 45

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 30

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 22

C07D - Heterocyclic Compounds 11

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 10

C07K - Peptides 10

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

Y02A - Technologies FOR Adaptation TO Climate Change 6

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 3

C12Y - Enzymes 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

C07C - Acyclic OR Carbocyclic Compounds 2

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 2

Top 15 of 23 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

The Translational Genomics Research Institute's patent record in context - here's where to go next.

The Translational Genomics Research Institute's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 62.9% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #3,513 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare The Translational Genomics Research Institute against Sony Pictures Entertainment Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.